BioCentury
ARTICLE | Financial News

Domain launches PD newco Mavalon

October 18, 2016 7:00 AM UTC

Domain Therapeutics S.A. (Strasbourg, France) said it launched single-asset, U.K.-based Parkinson's disease newco Mavalon Therapeutics with an investment of up to EUR 9 million ($9.9 million) from Medicxi Ventures. ...